[An experimental study on MR lymphography with various iron colloid agents].

Area of Science:

• Radiology
• Biomedical Imaging
• Nanotechnology

Background:

• Iron colloid agents are used for iron deficiency anemia.
• Magnetic resonance (MR) lymphography is a developing imaging technique.
• Understanding agent behavior in lymphatics is crucial for diagnostic applications.

Purpose of the Study:

• To evaluate the efficacy of different iron colloid agents for MR lymphography.
• To assess the time-dependent behavior and biodistribution of these agents in lymphatic systems.
• To correlate MR imaging findings with histological data.

Main Methods:

• Four iron colloid agents (ferric gluconate, saccharated ferric oxide, iron chondroitin sulfate, cideferron) were tested in a rabbit model.
• MR imaging was performed at 1.5 T using a spin-echo sequence before and after subcutaneous injection.
• Signal intensity changes in popliteal lymph nodes were analyzed and correlated with histological iron distribution.

Main Results:

• Ferric gluconate (FeG) at 4 mgFe showed a 50% increase in signal intensity within 5-60 minutes post-injection, returning to baseline after 48 hours.
• Saccharated ferric oxide (SFO), iron chondroitin sulfate (ICS), and cideferron (CiF) at their respective doses (8 mgFe, 1 mgFe, 1 mgFe) resulted in decreased signal intensity to background levels by 60 minutes and 48 hours.
• Histology confirmed that FeG particles in lymph increased signal intensity, whereas particles within macrophages for SFO, ICS, and CiF decreased signal intensity.

Conclusions:

• Ferric gluconate demonstrates potential as an MR lymphography contrast agent due to its lymph-enhancing properties.
• Other iron colloid agents, when taken up by macrophages, may not be suitable for MR lymphography applications requiring lymph node visualization.
• Agent-specific behavior in the lymphatic system dictates their utility in MR lymphography.